Skip to main content
SpringerLink
Log in

TACI, Isotype Switching, CVID, and IgAD

  • Conference paper
National Institute of Allergy and Infectious Diseases, NIH

Part of the book series: Infectious Disease ((ID))

  • 879 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mackay F, Kalled SL (2002) TNF ligands and receptors in autoimmunity: an update. Curr Opin Immunol 14:783–790.

    Article  PubMed  CAS  Google Scholar 

  2. Mackay F, Schneider P, Rennert P, Browning J (2003) BAFF and APRIL: A Tutorial on B Cell Survival. Annu Rev Immunol 21:231–264.

    Article  PubMed  CAS  Google Scholar 

  3. Bischof D, Elsawa SF, Mantchev G, Yoon J, Michels GE, Nil-son A, Sutor SL, Platt JL, Ansell SM, von Bulow G, Bram RJ (2006) Selective activation of TACI by syndecan 2. Blood 107:3235–3242.

    Article  PubMed  CAS  Google Scholar 

  4. Hendriks J, Planelles L, de Jong-Odding J, Hardenberg G, Pals S, Hahne M, Spaargaren M, Medema J (2005) Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ 12:637–648.

    Article  PubMed  CAS  Google Scholar 

  5. Ingold K, Zumsteg A, Tardivel A, Huard B, Steiner Q, Cachero T, Qiang F, Gorelik L, Kalled S, Acha-Orbea H, Rennert P, Tschopp J, Schneider P (2005) Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med 201:1375–1383.

    Article  PubMed  CAS  Google Scholar 

  6. Lopez-Fraga M, Fernandez R, Albar JP, Hahne M (2001) Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase. EMBO Rep 2:945–951.

    Article  PubMed  CAS  Google Scholar 

  7. Moreaux J, Cremer FW, Reme T, Raab M, Mahtouk K, Kaukel P, Pantesco V, De Vos J, Jourdan E, Jauch A, Legouffe E, Moos M, Fiol G, Goldschmidt H, Rossi JF, Hose D, Klein B (2005) The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 106:1021–1030.

    Article  PubMed  CAS  Google Scholar 

  8. Schwaller J, Schneider P, Mhawech-Fauceglia P McKee T, Myit S, Matthes T, Tschopp J, Donze O, Legal FA, Huard B (2006) Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B cell Lymphoma aggressiveness. Blood 109:331–338.

    Article  Google Scholar 

  9. Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M, Frew E, Scott ML (2001) An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001; 293:2111–2114.

    Article  Google Scholar 

  10. Gross JA, Dillon SR, Mudri S, Johnston J, Littau A, Roque R, Rixon M, Schou O, Foley KP, Haugen H, McMillen S, Waggie K, Schreckhise RW, Shoemaker K, Vu T, Moore M, Grossman A, Clegg CH (2001) TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity 15:289–302.

    Article  PubMed  CAS  Google Scholar 

  11. Castigli E, Scott S, Dedeoglu F, Bryce P, Jabara H, Bhan AK, Mizoguchi E, Geha RS (2004) Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci USA 101:3903–3908.

    Article  PubMed  CAS  Google Scholar 

  12. von Bulow GU, Bram RJ (1997) NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 278:138–141.

    Article  Google Scholar 

  13. von Bulow GU, van Deursen JM, Bram RJ (2001) Regulation of the T-independent humoral response by TACI. Immunity 14:573–582.

    Article  Google Scholar 

  14. Yan M, Wang H, Chan B, Roose-Girma M, Erickson S, Baker T, Tumas D, Grewal IS, Dixit VM (2001) Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol 2:638–643.

    Article  PubMed  CAS  Google Scholar 

  15. Seshasayee D, Valdez P Y a n M, Dixit VM, Tumas D, Grewal IS (2003) Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18:279–288.

    Article  PubMed  CAS  Google Scholar 

  16. Hymowitz S, Patel D, Wallweber H, Runyon S, Yan M, Yin J, Shriver S, Gordon N, Pan B, Skelton N, Kelley R, Starovas-nik M (2005) Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding. J Biol Chem 280:7218–7227.

    Article  PubMed  CAS  Google Scholar 

  17. Ni C, Oganesyan G, Welsh K, Zhu X, Reed J, Satterthwait A, Cheng G, Ely K (2004) Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation. J Immunol 173:7394–7400.

    PubMed  CAS  Google Scholar 

  18. Xia XZ, Treanor J, Senaldi G, Khare SD, Boone T, Kelley M, Theill LE, Colombero A, Solovyev I, Lee F, McCabe S, R. E, Miner K,Hawkins N, Guo J, Stolina M, Yu G, Wang J, Delaney J, Meng SY, Boyle WJ, Hsu H (2000) TACI is a TRAF-interact-ing receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J Exp Med 192:137–143.

    Article  PubMed  CAS  Google Scholar 

  19. Jabara H, Laouini D, Tsitsikov E, Mizoguchi E, Bhan A, Castigli E, Dedeoglu F, Pivniouk V, Brodeur S, Geha R (2002) The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching. Immunity 17:265–276.

    Article  PubMed  CAS  Google Scholar 

  20. Jabara HH, Geha RS (2005) Jun N-terminal kinase is essential for CD40-mediated IgE class switching in B cells. J Allergy Clin Immunol 115:856–863.

    Article  PubMed  CAS  Google Scholar 

  21. Ahonen C, Manning E, Erickson L, O'Connor B, Lind E, Pullen S, Kehry M, Noelle R (2002) The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells. Nat Immunol 3:451–456.

    Article  PubMed  CAS  Google Scholar 

  22. von Bulow GU, Russell H, Copeland NG, Gilbert DJ, Jenkins NA, Bram RJ (2000) Molecular cloning and functional characterization of murine transmembrane activator and CAML interactor (TACI) with chromosomal localization in human and mouse. Mamm Genome 11:628–632.

    Article  Google Scholar 

  23. Zhang X, Park C, Yoon S, Li L, Hsu Y, Ambrose C, Choi Y (2005) BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. Int Immunol 17:779–788.

    Article  PubMed  CAS  Google Scholar 

  24. O'Connor BP, Raman VS, Erickson LD, Cook WJ, Weaver LK, Ahonen C, Lin LL, Mantchev GT, Bram RJ, Noelle RJ (2004) BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 199:91–98.

    Article  PubMed  Google Scholar 

  25. Castigli E, Wilson SA, Scott S, Dedeoglu F, Xu S, Lam KP, Bram RJ, Jabara H, Geha RS (2005) TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 201:35–39.

    Article  PubMed  CAS  Google Scholar 

  26. Sasaki Y, Casola S, Kutok JL, Rajewsky K, Schmidt-Supprian M (2004) TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol 173:2245–2252.

    PubMed  CAS  Google Scholar 

  27. Shulga-Morskaya S, Dobles M, Walsh ME, Ng LG, MacKay F, Rao SP, Kalled SL, Scott ML (2004) B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J Immunol 173:2331–2341.

    PubMed  CAS  Google Scholar 

  28. Geha RS, Jabara HH, Brodeur SR (2003) The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol 3:721–732.

    Article  PubMed  CAS  Google Scholar 

  29. He B, Qiao X, Cerutti A (2004) CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol 173:4479–4491.

    PubMed  CAS  Google Scholar 

  30. Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A (2002) DCs induce CD40-independent immuno-globulin class switching through BLyS and APRIL. Nat Immunol 3:822–829.

    Article  PubMed  CAS  Google Scholar 

  31. Di Renzo M, Pasqui AL, Auteri A (2004) Common variable immunodeficiency: a review. Clin Exp Med 3:211–217.

    Article  PubMed  CAS  Google Scholar 

  32. Kokron CM, Errante PR, Barros MT, Baracho GV, Camargo MM, Kalil J, Rizzo LV (2004) Clinical and laboratory aspects of common variable immunodeficiency. An Acad Bras Cienc 76:707–726.

    PubMed  Google Scholar 

  33. Schroeder HW Jr Schroeder HW 3rd, Sheikh SM (2004) The complex genetics of common variable immunodeficiency. J Investig Med 52:90–103.

    PubMed  CAS  Google Scholar 

  34. Burrows PD, Cooper MD (1997) IgA deficiency. Adv Immunol 65:245–276.

    Article  PubMed  CAS  Google Scholar 

  35. Cunningham-Rundles C (2001) Physiology of IgA and IgA deficiency. J Clin Immunol 21:303–309.

    Article  PubMed  CAS  Google Scholar 

  36. Weston SA, Prasad ML, Mullighan CG, Chapel H, Benson EM (2001) Assessment of male CVID patients for mutations in the Btk gene: how many have been misdiagnosed? Clin Exp Immunol 124:465–469.

    Article  PubMed  CAS  Google Scholar 

  37. Eastwood D, Gilmour KC, Nistala K, Meaney C, Chapel H, Sherrell Z, Webster AD, Davies EG, Jones A, Gaspar HB (2004) Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency. Clin Exp Immunol 137:584–588.

    Article  PubMed  CAS  Google Scholar 

  38. Farrington M, Grosmaire L, Nonoyama S, Fischer S, Hollenbaugh D, Ledbetter J, Noelle R, Aruffo A, Ochs H (1994) CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci USA 91:1099–1103.

    Article  PubMed  CAS  Google Scholar 

  39. Grimbacher B, Hutloff A, Schlesier M, Glocker E, Warnatz K, Drager R, Eibel H, Fischer B, Schaffer AA, Mages HW, Kroczek RA, Peter HH (2003) Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 4:261–268.

    Article  PubMed  CAS  Google Scholar 

  40. Kralovicova J, Kusikova M, Buc M, Holomanova D, Sakalova A (2000)[Frequency of HLA-A, HLA-B and HLA-Cw antigens in the Slovak population]. Bratisl Lek Listy 101:24–27.

    PubMed  CAS  Google Scholar 

  41. Islam KB, Baskin B, Nilsson L, Hammarstrom L, Sideras P, Smith CI (1994) Molecular analysis of IgA deficiency. Evidence for impaired switching to IgA. J Immunol 152:1442–1452.

    PubMed  CAS  Google Scholar 

  42. Wang Z, Yunis D, Irigoyen M, Kitchens B, Bottaro A, Alt FW, Alper CA (1999) Discordance between IgA switching at the DNA level and IgA expression at the mRNA level in IgA-deficient patients. Clin Immunol 91:263–270.

    Article  PubMed  CAS  Google Scholar 

  43. Asano T, Kaneko H, Terada T, Kasahara Y, Fukao T, Kasahara K, Kondo N (2004) Molecular analysis of B-cell differentiation in selective or partial IgA deficiency. Clin Exp Immunol 136:284–290.

    Article  PubMed  CAS  Google Scholar 

  44. Islam KB, Nilsson L, Sideras P, Hammarstrom L, Smith CI (1991) TGF-beta 1 induces germ-line transcripts of both IgA subclasses in human B lymphocytes. Int Immunol 3:1099–1106.

    Article  PubMed  CAS  Google Scholar 

  45. Bonhomme D, Hammarstrom L, Webster D, Chapel H, Hermine O, Le Deist F, Lepage E, Romeo PH, Levy Y (2000) Impaired antibody affinity maturation process characterizes a subset of patients with common variable immunodeficiency. J Immunol 165:4725–4730.

    PubMed  CAS  Google Scholar 

  46. Levy Y, Gupta N, Le Deist F, Garcia C, Fischer A, Weill JC, Reynaud CA (1998) Defect in IgV gene somatic hypermutation in common variable immuno-deficiency syndrome. Proc Natl Acad Sci USA 95:13,135–13,140.

    CAS  Google Scholar 

  47. Andersen P, Permin H, Andersen V, Schejbel L, Garred P, Sve-jgaard A, Barington T (2005) Deficiency of somatic hypermu-tation of the antibody light chain is associated with increased frequency of severe respiratory tract infection in common variable immunodeficiency. Blood 105:511–517.

    Article  PubMed  CAS  Google Scholar 

  48. Castigli E, Wilson S, Garibyan L, Rachid R, Bonilla F, Schneider L, Geha R (2005) TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37:829–834.

    Article  PubMed  CAS  Google Scholar 

  49. Salzer U, Chapel HM, Webster AD, Pan-Hammarstrom Q, Schmitt-Graeff A, Schlesier M, Peter HH, Rockstroh JK, Schneider P, Schaffer AA, Hammarstrom L, Grimbacher B (2005) Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 37:820–828.

    Article  PubMed  CAS  Google Scholar 

  50. Reyes-Moreno C, Girouard J, Lapointe R, Darveau A, Mou-rad W (2004) CD40/CD40 homodimers are required for CD40-induced phosphatidylinositol 3-kinase-dependent expression of B7.2 by human B lymphocytes. J Biol Chem 279:7799–7806.

    Article  PubMed  CAS  Google Scholar 

  51. SiegelR,Frederiksen J,Zacharias D, ChanF,Johnson M, Lynch D, Tsien R, Lenardo M (2000) Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 288:2328–2329.

    Article  Google Scholar 

  52. Salzer U, Grimbacher B (2005) TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency. Curr Opin Allergy Clin Immunol 5:496–503.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Immunology, Children's Hospital, Boston, MA, USA

    Emanuela Castigli & Raif S. Geha

Authors
  1. Emanuela Castigli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raif S. Geha
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Vassil St. Georgiev PhD Karl A. Western MD John J. McGowan PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this paper

Cite this paper

Castigli, E., Geha, R.S. (2008). TACI, Isotype Switching, CVID, and IgAD. In: Georgiev, V.S., Western, K.A., McGowan, J.J. (eds) National Institute of Allergy and Infectious Diseases, NIH. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-59745-569-5_38

Download citation

Publish with us

Policies and ethics

Search

Navigation